• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Peginterferon alfa-2a Approval Information - Licensing Action

Proper name: Peginterferon alfa-2a
Tradename: PEGASYS
Manufacturer: Hoffman-La Roche, Inc, Nutley, NJ, License #0136
Indication for Use: Combination therapy with Ribavirin, USP (Copegus), for the treatment of chronic hepatitis C virus infection
Approval Date: 12/3/2002
Type of submission: Biologics license application supplement


Label (PDF)